IBR2 is a potent and specific RAD51 inhibitor and inhibits RAD51 -mediated DNA double-strand break repair. IBR2 disrupts RAD51 multimerization, accelerates proteasome-mediated RAD51 protein degradation, inhibits cancer cell growth and induces
IBR2 is a potent and specific RAD51 inhibitor and inhibits RAD51 -mediated DNA double-strand break repair. IBR2 disrupts RAD51 multimerization, accelerates proteasome-mediated RAD51 protein degradation, inhibits cancer cell growth and induces
IBR2 is a potent and specific RAD51 inhibitor and inhibits RAD51 -mediated DNA double-strand break repair. IBR2 disrupts RAD51 multimerization, accelerates proteasome-mediated RAD51 protein degradation, inhibits cancer cell growth and induces
IBR2 is a potent and specific RAD51 inhibitor and inhibits RAD51 -mediated DNA double-strand break repair. IBR2 disrupts RAD51 multimerization, accelerates proteasome-mediated RAD51 protein degradation, inhibits cancer cell growth and induces
HKOH-1r is a highly sensitive green fluorescent probe for the specific detection of ·OH in living cells with a maximum excitation wavelength and emission wavelength of 500 nm and 520 nm, respectively.In Vitro1. Preparation of HKOH-1r working
HKOH-1r is a highly sensitive green fluorescent probe for the specific detection of ·OH in living cells with a maximum excitation wavelength and emission wavelength of 500 nm and 520 nm, respectively.In Vitro1. Preparation of HKOH-1r working
HKOH-1r is a highly sensitive green fluorescent probe for the specific detection of ·OH in living cells with a maximum excitation wavelength and emission wavelength of 500 nm and 520 nm, respectively.In Vitro1. Preparation of HKOH-1r working
HKOH-1r is a highly sensitive green fluorescent probe for the specific detection of ·OH in living cells with a maximum excitation wavelength and emission wavelength of 500 nm and 520 nm, respectively.In Vitro1. Preparation of HKOH-1r working
HKOH-1r is a highly sensitive green fluorescent probe for the specific detection of ·OH in living cells with a maximum excitation wavelength and emission wavelength of 500 nm and 520 nm, respectively.In Vitro1. Preparation of HKOH-1r working
HKOH-1r is a highly sensitive green fluorescent probe for the specific detection of ·OH in living cells with a maximum excitation wavelength and emission wavelength of 500 nm and 520 nm, respectively.In Vitro1. Preparation of HKOH-1r working
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).
InformationOrelabrutinib (ICP-022) Orelabrutinib (ICP-022) is a potent, orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK) . Orelabrutinib has potential antineoplastic activity.TargetsBTKIn vitroOrelabrutinib potently
InformationOrelabrutinib (ICP-022) Orelabrutinib (ICP-022) is a potent, orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK) . Orelabrutinib has potential antineoplastic activity.TargetsBTKIn vitroOrelabrutinib potently
InformationOrelabrutinib (ICP-022) Orelabrutinib (ICP-022) is a potent, orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK) . Orelabrutinib has potential antineoplastic activity.TargetsBTKIn vitroOrelabrutinib potently
InformationOrelabrutinib (ICP-022) Orelabrutinib (ICP-022) is a potent, orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK) . Orelabrutinib has potential antineoplastic activity.TargetsBTKIn vitroOrelabrutinib potently